Caterina Peraldo‐Neia

Author

Also Known As

C Peraldo Neia, C Peraldo-Neia, C. Peraldo Neia, C. Peraldo-Neia, Caterina Peraldo Neia, Caterina Peraldo-Neia, Caterina Peraldo‐Neia, Caterina Peraldo‑Neia, Peraldo-Neia C, Peraldo-Neia, Caterina

Publications

950

Citations

H-Index

Concepts

All Affiliations

Fondazione Edo ed Elvo Tempia Candiolo Cancer Institute University of Turin University of Florence Istituti di Ricovero e Cura a Carattere Scientifico

About

Caterina Peraldo‐Neia is an author at Fondazione Edo ed Elvo Tempia specializing in medicine, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	149
2	Cell Biology	4	4	111
3	Engineering	1	1	34
4	Endocrinology	1	1	34
5	Hepatology	1	1	21

Caterina Peraldo‐Neia

Publications

799

Citations

H-Index

Page 1

	Year	Citations
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas Ymera Pignochino, Ivana Sarotto, Caterina Peraldo‐Neia, BMC Cancer	2010	172
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer Caterina Peraldo‐Neia, Giorgia Migliardi, Maurizia Mello‐Grand, BMC Cancer	2011	95
The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma Margherita Correnti, A. Cappon, Mirella Pastore, Liver International	2021	62
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib Giorgio Valabrega, Sonia Capellero, Giuliana Cavalloni, Breast Cancer Research and Treatment Breast OncologyOncologyLose RelianceMedicineBreast Cancer	2010	48
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation Giuliana Cavalloni, Caterina Peraldo‐Neia, Francesco Sassi, BMC Cancer	2016	44
Identification of Novel Circulating microRNAs in Advanced Heart Failure by Next-Generation Sequencing Alessandro Galluzzo, Simona Gallo, Barbara Pardini, ESC Heart Failure	2021	43
Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer Filippo Montemurro, Aleix Prat, Valentina Rossi, Molecular Oncology	2013	42
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient Giuliana Cavalloni, Caterina Peraldo‐Neia, Chiara Varamo, Tumor Biology	2015	40
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma Paola Ostano, Maurizia Mello‐Grand, Debora Sesia, International Journal of Molecular Sciences Systems BiologyUrologyEngineeringGenitourinary CancerMedicine	2020	34
Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine Chiara Varamo, Caterina Peraldo‐Neia, Paola Ostano, Cancers	2019	28

Page 1